Gli ultimi aggiornamenti dal congresso ATS (American Thoracic Society) 2021
Report sui principali dati presentati in BPCO
![]() |
Il Dr. Richard Russel (Università di Oxford, UK) e il Dr. Surya Bhatt (Università dell’Alabama a Birmingham, USA) descrivono:
What next? Looking ahead in COPD
Treatment personalization in COPD
The impact of symptoms on patient outcome
Making the right choice for our patients
ICS in COPD: Not One Size Fits All
How does the inhalation Ability of patients influence treatment decision?
ARTICOLI CORRELATI
![img-card img-card](/it/medaffairs/sites/default/files/2022-09/image-card.png)
ATTUALITÀ
Tiotropium/Olodaterol Improves Lung Function in COPD Patients Stratified by Peak Inspiratory Flow
I risultati dello studio TRONARTO –Dati presentati da Mahler DA et al. congresso ATS 2021
![img-card img-card](/it/medaffairs/sites/default/files/2022-09/image-card.png)
ATTUALITÀ
A Pooled Analysis of Mortality in Patients with COPD
Confronto tripla terapia vs doppia broncodilatazione -Dati presentati da Miravitless M et al. congresso ATS 2021
![img-card img-card](/it/medaffairs/sites/default/files/2022-09/image-card.png)
ATTUALITÀ
Peak inspiratory flow measured against the resistance of two common DPI in COPD patients
Ohar J et al. poster presentato al congresso ATS 2021